2015•The Lancet Infectious DiseasesOpen access

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial

Larisa G. Rudenko, Irina N. Isakova-Sivak, Anatoly Naykhin, Irina Kiseleva, Marina Stukova, М. К. Ерофеева, Daniil A. Korenkov, Victoria Matyushenko, Erin Grace Sparrow, Marie-Paule Kiény

Open full text 42 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 42 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Placebo, Seroconversion, Adverse effect, Influenza vaccine, Live attenuated influenza vaccine, Immunogenicity, Vaccination

Back to paper search Browse research topics Original source

H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial — Research Paper | ScholarLens